Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 146
- Uncategorized
US recommendation to reschedule cannabis marks ‘significant shift in drug policy’ and ‘new opportunities’ for industry
The US Department of Health and Human Services (HHS) recommendation to reschedule cannabis marks a significant shift in drug policy, untangling decades of prohibition and offering new opportunities for the industry, writes FoxNRTH’s Principal, Chris Murray.
- Uncategorized
North Carolina Stop Pot Act Would Slash Funding for Native Tribes
The new ‘Stop Pot Act’ introduced in North Carolina by Congressman Chuck Edwards would see funding cut for states and native tribes that legalise recreational cannabis.
- Uncategorized
How cannabis rescheduling could create new opportunities for banking
Last week, the U.S Department of Health and Human Services (HHS) urged the Drug Enforcement Administration (DEA) to reclassify cannabis from Schedule I to Schedule III under federal law.
- Opinion
Switzerland’s ‘Pragmatic Not Political’ Approach To Cannabis Reform Should Set Precedent
Last week saw the launch of ZüriCan, Switzerland’s second cannabis pilot set to give over 2000 Zurich inhabitants legal access to adult-use cannabis.
- Uncategorized
Connecticut Launches Social Equity Fund for Cannabis Businesses
Connecticut has officially launched its Canna-Business Revolving Loan Fund (CBRLF).
- Uncategorized
Decibel Expands Global Footprint into UK Medical Cannabis Market
Canada-based Decibel is expanding its global footprint through a new supply agreement to provide premium dried medical cannabis flower to the United Kingdom’s 4C LABS. 4C Labs is a healthcare, technology and pharmaceutical company focused on virtual prescribing, pharmaceutical distribution and clinical development in cannabis-based medicinal products in the UK.
- CBD Market
Italy’s CBD Industry Faces New Blow as Government Decrees CBD Oil as Narcotic Substance
Italy’s government has taken aim at CBD once again, issuing a new decree set to class CBD oil as a narcotic substance.
- Uncategorized
Stocks Rally Following Leaked Cannabis Rescheduling Letter
Cannabis stocks are rallying after a letter was leaked to Bloomberg on Wednesday revealing that The U.S Department of Health and Human Services (HHS) has recommended the Drug Enforcement Administration (DEA) reclassify cannabis from Schedule I to Schedule III under federal law.
- Uncategorized
HHS Recommends Reclassifying Cannabis from Schedule I to Schedule III Under Federal Law
The U.S Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA) recommending that cannabis be reclassified from Schedule I to Schedule III under federal law.
- Markets & Stocks
MGC Pharma Raises A$834k in Share Purchase Plan, & More From DanCann Pharma
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals announced the closure of its share purchase plan (SPP) this week, seeing the company successfully raise a further A$834k (£426k).
- Data & Analysis
Pharmaceutical Cannabis Players Are Driving Technological Innovation Across The Value Chain
The slow but steady march of pharmaceutical players into the cannabis industry has spurned a new period of technological innovation, bringing new techniques and technologies to every part of the cannabis value chain.
- Press releases
Mamedica Launches First Own-Brand Strains of Canadian THC-Dominant Cannabis in the UK With Cantourage
Mamedica® – the UK’s fastest-growing medical cannabis clinic, has partnered with Cantourage UK to launch the first of its own-branded products in the UK.
